Streptavidin expressed gene fusions and methods of use thereof
US7144991B2 · kind B2 · utility
22Cited by
16References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2001 |
| Grant date | Dec 5, 2006 |
| Priority date | — |
| Expiry date | Dec 7, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides vectors for expressing genomic streptavidin fusion cassettes. In the various embodiments, fusion proteins produced from these vectors are provided. In particular embodiments, fusion proteins comprising a single chain antibody and genomic streptavidin are provided as are vectors encoding the same. Also provided, are methods of using the fusion proteins of the present invention, and in particular, the use of scFvSA fusion proteins as diagnostic markers or as a cell specific targeting agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.